Innovations in Digital and Targeted Treatment Platforms, 2018 Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 19, 2018--The “Innovations in Digital and Targeted Treatment Platforms” report has been added to ResearchAndMarkets.com’s offering.
This Genetic Technology TOE depicts new life sciences trends across digital targeted therapeutic platforms. Human genetics, antibody therapies, digital oncology platforms, among others, are profiled. The clinical trials scenario for FoundationOne Platform is along depicted.
Key Topics Covered:
1. Advancements in Digital and Targeted Treatment PlatformsFueling Digital Therapy Platforms Leveraging Human Genetics for Drug Target Discovery Enabling Affordable Antibody Therapies Merging Precision Oncology Platforms for Personalized Healthcare
2. Clinical Trial Analysis and Key ContactsAnalysis of Completed/Ongoing Clinical Trials for Foundation - One Platform Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/jfz4kz/innovations_in?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180919005708/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/19/2018 02:11 PM/DISC: 09/19/2018 02:11 PM